A review on diabetes and oral cancer: Molecular links and implications

Document Type : Invited review article

Authors

Clinical Genetics Lab, Centre Cellular and Molecular Research (The Blue Lab), Saveetha Dental College & Hospital, Saveetha Institute of Medical and Technical Sciences [SIMATS], Saveetha University, Chennai, Tamil Nadu, India

Abstract

Diabetes mellitus has been linked to an increased risk of oral cancer, with hyperglycemia and chronic inflammation contributing to malignant transformation. Accumulating evidence has highlighted the role of specific genes and biomarkers associated with the process. While hyperglycemia accelerates cancer progression, Metformin, an anti-diabetic medication, is found to reduce the recurrence. Future research should focus on understanding molecular mechanisms, developing early diagnostic tools, and assessing the impact of glycemic control in managing potentially oral malignant lesions in diabetic patients.

Keywords

References

  1. Ye J, Wu Y, Yang S, Zhu D, Chen F, Chen J, Ji X, Hou K. The global, regional and national burden of type 2 diabetes mellitus in the past, present and future: a systematic analysis of the Global Burden of Disease Study 2019. Front Endocrinol (Lausanne) 2023;14:1192629.
  2. Shahid RK, Ahmed S, Le D, Yadav S. Diabetes and cancer: risk, challenges, management and outcomes. Cancers (Basel) 2021;13:5735.
  3. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D. Diabetes and cancer: a consensus report. Diabetes Care 2010;33: 1674-1685.
  4. Xu W, Chen Z, Zhang L. Impact of diabetes on the prognosis of patients with oral and oropharyngeal cancer: A meta-analysis. J Diabetes Investig 2024;15:1140-1150.
  5. Ramos-Garcia P, Roca-Rodriguez MDM, Aguilar-Diosdado M, Gonzalez-Moles MA. Diabetes mellitus and oral cancer/oral potentially malignant disorders: A systematic review and meta-analysis. Oral Dis 2021;27:404-421.
  6. Gupta A, Singh N, Kumar A, Verma UP, Verma AK, Shyam H, Lal N, Kant S, Kumari A. Differential expression of inflammatory responsive genes between chronic periodontitis and periodontally affected bronchiectasis patients. Mol Biol Res Commun 2020;9:169-172.
  7. Ezhilarasan D, Varghese SS. Porphyromonas gingivalis and dental stem cells crosstalk amplify inflammation and bone loss in the periodontitis niche. J Cell Physiol 2022;237: 3768-3777.
  8. Goertzen C, Mahdi H, Laliberte C, Meirson T, Eymael D, Gill-Henn H, Magalhaes M. Oral inflammation promotes oral squamous cell carcinoma invasion. Oncotarget 2018;9:29047-29063.
  9. Syed VA, Ramamurthy J. Evaluation of TREM1 gene expression in stage II grade A periodontitis patients with type 2 diabetes mellitus: An ex-vivo study. J Clin of Diagn Res 2024;18:ZC63-ZC66.
  10. Fan Y, Zhang J, Shi J, Chen L, Long J, Zhang S, Liu S. Genetic cross-talk between oral squamous cell carcinoma and type 2 diabetes: The potential role of immunity. Dis Markers 2022;2022:6389906.
  11. Nakazato K, Mogushi K, Kayamori K, Tsuchiya M, Takahashi KI, Sumino J, Michi Y, Yoda T, Uzawa N. Glucose metabolism changes during the development and progression of oral tongue squamous cell carcinomas. Oncol Lett 2019;18:1372-1380.
  12. Remschmidt B, Pau M, Gaessler J, Zemann W, Jakse N, Payer M, Vegh D. Diabetes mellitus and oral cancer: A retrospective study from Austria. Anticancer Res 2022;42: 1899-1903.
  13. Kim GJ, Han KD, Joo YH. Association of metabolic syndrome with the risk of head and neck cancer: A 10-year follow-up study of 10 million initially healthy individuals. Cancers (Basel) 2023;15:4118.
  14. Vegh A, Banyai D, Ujpal M, Somogyi KS, Biczo Z, Kammerhofer G, Nemeth Z, Hermann P, Payer M, Vegh D. Prevalence of diabetes and impaired fasting glycemia in patients with oral cancer: A retrospective study in Hungary. Anticancer Res 2022;42:109-113.
  15. Hu X, Wu J, Xiong H, Zeng L, Wang Z, Wang C, Huang D, Zhang T, Peng Y, Chen W, Xie K, Su T. Type 2 diabetes mellitus promotes the proliferation, metastasis, and suppresses the apoptosis in oral squamous cell carcinoma. J Oral Pathol Med 2022;51:483-492.
  16. Vincent EE, Yaghootkar H. Using genetics to decipher the link between type 2 diabetes and cancer: shared aetiology or downstream consequence?. Diabetologia 2020;63:1706-1717.
  17. Chen LC, Lo YS, Ho HY, Lin CC, Chuang YC, Chang WC, Hsieh MJ. LDL Receptor-related protein 1B polymorphisms associated with increased risk of lymph node metastasis in oral cancer group with diabetes mellitus. Int J Mol Sci 2024;25:3963.
  18. Salehi AM, Wang L, Gu X, Coates PJ, Spaak LN, Sgaramella N, Nylander K. Patients with oral tongue squamous cell carcinoma and co‑existing diabetes exhibit lower recurrence rates and improved survival: Implications for treatment. Oncol Lett 2024;27:142.
  19. Hu X, Xiong H, Chen W, Huang L, Mao T, Yang L, Wang C, Huang D, Wang Z, Yu J, Shu Y, Xia K, Su T. Metformin reduces the increased risk of oral squamous cell carcinoma recurrence in patients with type 2 diabetes mellitus: A cohort study with propensity score analyses. Surg Oncol 2020;35:453-459.
  20. Peña-Romero AC, Orenes-Piñero E. Dual effect of immune cells within tumour micro-environment: Pro- and anti-tumour effects and their triggers. Cancers (Basel) 2022;14:1681.
  21. Muthumanickam P, Ramasubramanian A, Pandi C, Ramani P, Jayaseelan VP, Arumugam P. The novel m6A writer methyltransferase 5 is a promising prognostic biomarker and associated with immune cell infiltration in oral squamous cell carcinoma. J Oral Pathol Med 2024;53:521-529.
  22. Peppa M, Manta A, Mavroeidi I, Nastos C, Pikoulis E, Syrigos K, Bamias A. Dietary approach of patients with hormone-related cancer based on the glycemic index and glycemic load estimates. Nutrients 2023;15:3810.
  23. Bs A, P A, As SG, A P, J VP. Analysis of differentially expressed genes in dysplastic oral keratinocyte cell line and their role in the development of HNSCC. J Stomatol Oral Maxillofac Surg 2024;125(4S):101928.
  24. Wisniewski DJ, Ma T, Schneider A. Fatty acid synthase mediates high glucose-induced EGFR activation in oral dysplastic keratinocytes. J Oral Pathol Med 2021;50:919-926.
  25. Ma T, Montaner S, Schneider A. Glucose upregulates amphiregulin in oral dysplastic keratinocytes: A potential role in diabetes-associated oral carcinogenesis. J Oral Pathol Med 2023;52:1004-1012. 

Files

Share

How to cite

Statistics